Current funding opportunities include:
UKRI Digital Research Technical Professional Skills NetworkPlus (Grant)
Opening Date: 22 April 2024, 9:00am
Closing Date: 2 October 2024, 4:00pm
Scope:
Apply for funding for a Digital Research Technical Professional (RTP) Skills NetworkPlus, which brings together disciplines, sectors, and domains to address cross-cutting challenges related to digital RTP skills and careers.
You will provide leadership, coordinate collaborations, seed better ways of working, and catalyse learning, capability, and capacity for digital RTPs.
You must be based at a UK research organisation eligible for UKRI funding.
The full economic cost (FEC) of the awards can be up to £2,000,000. UKRI will fund 80% of the FEC. Awards will start by 1 April 2025 for up to 48 months.
Competition opens: 3 May 2024
Competition closes: 19 July 2024, 2pm
Scope:
ARIA is an R&D funding agency built to unlock scientific and technological breakthroughs that benefit everyone. We empower scientists and engineers to pursue research at the edge of what is technologically or scientifically possible. We reach across disciplines, sectors and institutions to shape, fund and manage projects across the R&D ecosystem, from startups to universities, to break down silos and discover new pathways. We’re looking for proposals for Activation Partners who will unlock latent ideas, empower talent, support new ventures, and provide insights and connectivity across our opportunity spaces. For more info see https://www.aria.org.uk/activation-partners.
SBRI Healthcare: Competition 25 – AMR
Opening Date: 17 July 2024
Closing Date: 28 August 2024
Scope:
The NHS Long Term Plan identifies antimicrobial resistance as one of five priorities requiring NHS action on prevention, and reiterates the UK’s 20-year vision for AMR which outlines the aim for a world in which antimicrobial resistance is effectively contained, controlled and mitigated.
Under the overall theme of “Antimicrobial resistance (AMR)”, Competition 25 Phase 1 invites early-stage innovations in the following four priority areas:
- Point of care diagnostics, monitoring, and susceptibility testing
- Prescribing decision support and risk stratification
- Novel care delivery methods
- Infection prevention and control (IPC).
Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.
SBRI Healthcare: Competition 25 – Women’s Health
Opening Date: 17 July 2024
Closing Date: 28 August 2024
Scope:
Under the overall theme of “Women’s Health”, Competition 25 Phase 1 invites early-stage innovations in the following three priority areas:
- Gynaecological Conditions and Hormonal Health
- Mental Health
- Chronic Conditions and Long-term Health.
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
Single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities, and NHS providers, given a strong commercial strategy is provided, are eligible to apply.
Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.
SBRI Healthcare: Competition 26 – Stroke
Opening Date: 31 July 2024
Closing Date: 18 September 2024
Scope:
The aim of the competition is to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to accelerate the uptake of the innovation into relevant health or social care settings.
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
The upper funding limit of SBRI Healthcare Phase 3 competitions is £500,000 excluding VAT.
SBRI Healthcare: Urgent & Emergency Care
Opening Date: 31 July 2024
Closing Date: 18 September 2024
Scope:
Competition 26 – Urgent & Emergency Care, Phase 3, aims to identify innovations at an advanced stage of development that address three priority areas:
- Health and Care outside of Hospitals: Accessing the Right Care and Reducing Demand
- Reducing Length of Stay and Improving Discharge
- Supporting Workforce.
The aim of the competition is to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to accelerate the uptake of the innovation into relevant health or social care settings.
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
The upper funding limit of SBRI Healthcare Phase 3 competitions is £500,000 excluding VAT.
UK-Singapore Collaborative R&D 2024
Scope:
Innovate UK, part of UK Research and Innovation, will invest up to £5 million in innovation projects in partnership with Enterprise Singapore. This competition has an open scope and UK registered organisations must collaborate with at least one Singapore registered business applying under the equivalent Enterprise Singapore programme.
Singapore partners must apply to and will be funded by Enterprise Singapore.
The projects are expected to result in a new product, industrial process or service. They must be innovative, involve a technological development and have high market potential in the participating countries.
UK applicants can apply for a maximum grant of up to £750,000 for a project.
Competition closes: Wednesday 28 August 2024 at 11:00am
Horizon Europe Guarantee – EIT KICs 2023
Scope:
The ’Horizon Europe guarantee’ scheme provides funding to researchers and innovators unable to receive their Horizon Europe funding while the UK is in the process of associating to the programme. The guarantee is a short-term measure intended to address the delays in the formalisation of the UK’s association to Horizon Europe.
This guarantee covers the costs of EIT-eligible activities delivered by UK participants of the KICs in 2021, 2022, and 2023 that would otherwise have been covered by grant funding awarded by EIT.
Registration Closes: Tuesday 31st December 2024
BridgeAI: Turing Commons | The Alan Turing Institute
Scope:
The ‘Turing Commons’ is for researchers, ethicists, sociologists, policymakers, or anyone with an interest in responsible data-driven technology. There are three skills tracks, each aimed at a different audience:
- Responsible Research and Innovation (RRI) – primarily for researchers with an active interest in data science or AI research and innovation.
- Public Engagement of Data Science and AI (PED) – primarily for researchers with an active interest in public engagement, specifically in the context of data science and artificial intelligence.
- AI Ethics & Governance (AEG) – primarily for researchers with an active interest in the ethics and governance of data science and AI.
Registration Closes: Tuesday 31 December 2024
Longstanding funding opportunities:
EIC Accelerator (UK based organisations are eligible)
The EIC Accelerator supports individual small and medium enterprises (SMEs) to develop and scale game-changing innovations providing substantial financial support with:
grant funding (non-dilutive) of up to €2.5 million for innovation development costs, including demonstration of the technology in the relevant environment, prototyping and system level demonstration, R&D and testing required to meet regulatory and standardisation requirements, intellectual property management, and marketing approval (e.g. at least TRL 5/6 to 8).
investments (direct equity investments or quasi-equity such as convertible loans- for EU based organisations only) of up to €15 million managed by the EIC Fund for scale up and other relevant costs.
The Innovate UK Smart grant funds a cross-sector portfolio to support SMEs and their partners to develop the best game changing and word-leading projects. Applications can come from any area of technology and be applied to any part of the economy. Projects of 6 to 18 months must have total eligible project costs between £100,000 and £500,000 and can be single or collaborative. 19 to 36 month projects must have total eligible project costs between £100,000 and £2 million and must be collaborative.
TheHill is always open to collaborations and keen to partner with other organisations as consortium member on collaborative projects, if you are interested please complete our triage form.